AMPE
Ampio Pharmaceuticals Inc
A biopharmaceutical developer based in Englewood, Colorado, focused on treatments for inflammatory conditions. Its lead drug candidate, Ampion, is a microscopic fragment of human serum albumin—the most abundant protein in blood—designed to be injected directly into the knee to ease osteoarthritis pain. Founded in 2008 by emergency physician David Bar-Or, the company had operated as Chay Enterprises until it took the Ampio name in 2010.
CUSIP: 03209T109HealthcareUS1 holder
Total Value
$34.0K
Total Shares
10.0K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
